intrommune_icon_500x500.png
Intrommune Therapeutics Presents Supporting Data Introducing a New Form of Food Allergy Treatment
February 22, 2024 09:34 ET | Intrommune Therapeutics
OMIT (Oral Mucosal Immunotherapy) is a new approach to the management of food allergy demonstrating a robust immunologic response in treated subjects
roche-logo-blue.png
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
February 16, 2024 11:24 ET | F. Hoffmann-La Roche Ltd
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate...
AAFA Statement on Uber Eats Super Bowl Ad
AAFA Statement on Uber Eats Super Bowl Ad
February 08, 2024 15:20 ET | Asthma and Allergy Foundation of America
Washington, DC, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) issued the following statement which may be attributed to Kenneth Mendez, president and CEO:  ...
22157.jpg
Food Allergy Market to Witness Remarkable Growth, Key Insights, and Global Outlook Revealed in New 2031 Forecast Report
February 06, 2024 10:06 ET | Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Food Allergy Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to...
intrommune_icon_500x500.png
Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
February 06, 2024 09:34 ET | Intrommune Therapeutics
New study is the first to evaluate Oral Mucosal Immunotherapy (OMIT) for the treatment of food allergy
UPDATE Latitude Food
UPDATE Latitude Food Allergy Care Announces the Opening of its Second New York City Location; Brooklyn Heights Clinic Will Provide Exceptional Food Allergy Care
February 01, 2024 10:01 ET | Latitude Food Allergy Care
Redwood City, CA and New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Latitude Food Allergy Care, the leading network of clinics providing life-changing testing and treatment, including oral...
Astonish Media Group
Astonish Media Group Announces Latitude Food Allergy Care Joins its Prestigious Portfolio of Clients
January 17, 2024 12:40 ET | Astonish Media Group
NewYork, NY, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Astonish Media Group, a leading boutique public relations and media strategy firm based in New York City, announces the addition of Latitude Food...
intrommune_icon_500x500.png
Inimmune Corporation and Intrommune Therapeutics announce a collaboration to advance a revolutionary rapid, long-acting oral mucosal allergy immunotherapy for the treatment of peanut allergy
January 08, 2024 09:05 ET | Intrommune Therapeutics
Inimmune Corporation and Intrommune Therapeutics announce a collaboration to advance a revolutionary rapid, long-acting oral mucosal allergy immunotherapy
22157.jpg
US Food Allergen Testing Market Outlook to 2028 - New York Commands Attention in the Eastern Region with Innovative Allergens Detection Technology
December 14, 2023 11:08 ET | Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "US Food Allergen Testing Market Outlook to 2028" report has been added to ResearchAndMarkets.com's offering. With the increasing prevalence of food...
intrommune_icon_500x500.png
Intrommune Therapeutics Presents Positive Results of Phase 1 OMEGA Study Investigating the Safety of INT301 Toothpaste for the Treatment of Peanut Allergy
November 09, 2023 11:01 ET | Intrommune Therapeutics
Intrommune Therapeutics Presents Positive Results of Phase 1 OMEGA Study Investigating the Safety of INT301 Toothpaste for the Treatment Peanut Allergy